Literature DB >> 21523346

Abolition of the behavioral phenotype of adult netrin-1 receptor deficient mice by exposure to amphetamine during the juvenile period.

Leora Yetnikoff1, Anne Almey, Andreas Arvanitogiannis, Cecilia Flores.   

Abstract

RATIONALE: Netrin-1 guidance cues contribute to amphetamine-induced plasticity of the adult mesocorticolimbic dopamine system in rodents. The netrin-1 receptor, deleted in colorectal cancer (DCC), is upregulated by repeated amphetamine treatment selectively in the ventral tegmental area (VTA) of adult rats and wild-type mice. Furthermore, adult dcc heterozygous mice fail to show amphetamine-induced increases in VTA DCC expression and do not develop sensitization to this drug.
OBJECTIVES: The effects of netrin-1 receptor signaling on mesocorticolimbic dopamine system function change across development. However, the effects of AMPH on DCC receptor regulation and behavioral sensitization before puberty have not been determined. Here we examined whether (1) repeated amphetamine treatment would also alter DCC expression in juvenile rats and wild-type mice, and (2) dcc heterozygotes treated with amphetamine during the juvenile period (PND 22-32) would develop behavioral sensitization to this drug.
RESULTS: Repeated amphetamine downregulates DCC expression selectively in the VTA of juvenile rodents. Moreover, the behavioral phenotype of adult dcc heterozygous mice is not present before puberty and is abolished by amphetamine treatment during the juvenile period. Remarkably, adult dcc heterozygotes pretreated with amphetamine as juveniles no longer exhibit reduced DCC expression in the VTA compared to wild-type controls.
CONCLUSIONS: Our results indicate that netrin-1 receptor signaling may be a key factor in determining individual differences in vulnerability to the behaviorally sensitizing effects of amphetamine at different ages. Moreover, they suggest that the juvenile period marks a window of vulnerability during which exposure to stimulant drugs can reverse the behavioral phenotype of adult dcc heterozygous mice.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21523346     DOI: 10.1007/s00213-011-2312-6

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  47 in total

1.  Development of the dopaminergic innervation in the prefrontal cortex of the rat.

Authors:  A Kalsbeek; P Voorn; R M Buijs; C W Pool; H B Uylings
Journal:  J Comp Neurol       Date:  1988-03-01       Impact factor: 3.215

2.  Localization of immunoreactivity for deleted in colorectal cancer (DCC), the receptor for the guidance factor netrin-1, in ventral tier dopamine projection pathways in adult rodents.

Authors:  P B Osborne; G M Halliday; H M Cooper; J R Keast
Journal:  Neuroscience       Date:  2005       Impact factor: 3.590

Review 3.  AMPA receptor synaptic plasticity induced by psychostimulants: the past, present, and therapeutic future.

Authors:  M Scott Bowers; Billy T Chen; Antonello Bonci
Journal:  Neuron       Date:  2010-07-15       Impact factor: 17.173

4.  The netrin receptor DCC is required in the pubertal organization of mesocortical dopamine circuitry.

Authors:  Colleen Manitt; Andrea Mimee; Conrad Eng; Matthew Pokinko; Thomas Stroh; Helen M Cooper; Bryan Kolb; Cecilia Flores
Journal:  J Neurosci       Date:  2011-06-08       Impact factor: 6.167

5.  Netrin receptor deficient mice exhibit functional reorganization of dopaminergic systems and do not sensitize to amphetamine.

Authors:  C Flores; C Manitt; D Rodaros; K M Thompson; H Rajabi; K C Luk; N X Tritsch; A F Sadikot; J Stewart; T E Kennedy
Journal:  Mol Psychiatry       Date:  2005-06       Impact factor: 15.992

Review 6.  Where the rubber meets the road: netrin expression and function in developing and adult nervous systems.

Authors:  Colleen Manitt; Timothy E Kennedy
Journal:  Prog Brain Res       Date:  2002       Impact factor: 2.453

7.  Netrin-1 receptor-deficient mice show enhanced mesocortical dopamine transmission and blunted behavioural responses to amphetamine.

Authors:  Alanna Grant; Daniel Hoops; Cassandre Labelle-Dumais; Michael Prévost; Heshmat Rajabi; Bryan Kolb; Jane Stewart; Andreas Arvanitogiannis; Cecilia Flores
Journal:  Eur J Neurosci       Date:  2007-11-14       Impact factor: 3.386

8.  Glia promote local synaptogenesis through UNC-6 (netrin) signaling in C. elegans.

Authors:  Daniel A Colón-Ramos; Milica A Margeta; Kang Shen
Journal:  Science       Date:  2007-10-05       Impact factor: 47.728

9.  Netrin participates in the development of retinotectal synaptic connectivity by modulating axon arborization and synapse formation in the developing brain.

Authors:  Colleen Manitt; Angeliki M Nikolakopoulou; David R Almario; Sarah A Nguyen; Susana Cohen-Cory
Journal:  J Neurosci       Date:  2009-09-09       Impact factor: 6.167

Review 10.  Netrins and their receptors.

Authors:  Simon W Moore; Marc Tessier-Lavigne; Timothy E Kennedy
Journal:  Adv Exp Med Biol       Date:  2007       Impact factor: 2.622

View more
  16 in total

Review 1.  The Netrin-1/DCC Guidance Cue Pathway as a Molecular Target in Depression: Translational Evidence.

Authors:  Angélica Torres-Berrío; Giovanni Hernandez; Eric J Nestler; Cecilia Flores
Journal:  Biol Psychiatry       Date:  2020-05-11       Impact factor: 13.382

2.  Early Adolescence is a Critical Period for the Maturation of Inhibitory Behavior.

Authors:  Lauren M Reynolds; Leora Yetnikoff; Matthew Pokinko; Michael Wodzinski; Julia G Epelbaum; Laura C Lambert; Marie-Pierre Cossette; Andreas Arvanitogiannis; Cecilia Flores
Journal:  Cereb Cortex       Date:  2019-08-14       Impact factor: 5.357

3.  Amphetamine in adolescence disrupts the development of medial prefrontal cortex dopamine connectivity in a DCC-dependent manner.

Authors:  Lauren M Reynolds; Carolina S Makowski; Sandra V Yogendran; Silke Kiessling; Nicolas Cermakian; Cecilia Flores
Journal:  Neuropsychopharmacology       Date:  2015-03-13       Impact factor: 7.853

Review 4.  Making Dopamine Connections in Adolescence.

Authors:  Daniel Hoops; Cecilia Flores
Journal:  Trends Neurosci       Date:  2017-10-09       Impact factor: 13.837

5.  Dcc haploinsufficiency regulates dopamine receptor expression across postnatal lifespan.

Authors:  Matthew Pokinko; Alanna Grant; Florence Shahabi; Yvan Dumont; Colleen Manitt; Cecilia Flores
Journal:  Neuroscience       Date:  2017-01-17       Impact factor: 3.590

6.  Netrin-1 receptor-deficient mice show age-specific impairment in drug-induced locomotor hyperactivity but still self-administer methamphetamine.

Authors:  Jee Hyun Kim; Doron Lavan; Nicola Chen; Cecilia Flores; Helen Cooper; Andrew J Lawrence
Journal:  Psychopharmacology (Berl)       Date:  2013-07-03       Impact factor: 4.530

7.  DCC Receptors Drive Prefrontal Cortex Maturation by Determining Dopamine Axon Targeting in Adolescence.

Authors:  Lauren M Reynolds; Matthew Pokinko; Angélica Torres-Berrío; Santiago Cuesta; Laura C Lambert; Esther Del Cid Pellitero; Michael Wodzinski; Colleen Manitt; Paul Krimpenfort; Bryan Kolb; Cecilia Flores
Journal:  Biol Psychiatry       Date:  2017-06-16       Impact factor: 13.382

8.  Protracted maturation of forebrain afferent connections of the ventral tegmental area in the rat.

Authors:  Leora Yetnikoff; Rhett A Reichard; Zachary M Schwartz; Kenneth P Parsely; Daniel S Zahm
Journal:  J Comp Neurol       Date:  2014-04-01       Impact factor: 3.215

9.  Non-Contingent Exposure to Amphetamine in Adolescence Recruits miR-218 to Regulate Dcc Expression in the VTA.

Authors:  Santiago Cuesta; José Maria Restrepo-Lozano; Steven Silvestrin; Dominique Nouel; Angélica Torres-Berrío; Lauren M Reynolds; Andreas Arvanitogiannis; Cecilia Flores
Journal:  Neuropsychopharmacology       Date:  2017-11-20       Impact factor: 7.853

10.  Resilience to amphetamine in mouse models of netrin-1 haploinsufficiency: role of mesocortical dopamine.

Authors:  Matthew Pokinko; Luc Moquin; Angélica Torres-Berrío; Alain Gratton; Cecilia Flores
Journal:  Psychopharmacology (Berl)       Date:  2015-08-12       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.